Matches in Wikidata for { <http://www.wikidata.org/entity/Q37292354> ?p ?o ?g. }
- Q37292354 description "article científic" @default.
- Q37292354 description "article scientifique" @default.
- Q37292354 description "articolo scientifico" @default.
- Q37292354 description "artigo científico" @default.
- Q37292354 description "artículu científicu espublizáu en 2016" @default.
- Q37292354 description "bilimsel makale" @default.
- Q37292354 description "scientific article published on 28 September 2016" @default.
- Q37292354 description "vedecký článok" @default.
- Q37292354 description "vetenskaplig artikel" @default.
- Q37292354 description "videnskabelig artikel" @default.
- Q37292354 description "vědecký článek" @default.
- Q37292354 description "wetenschappelijk artikel" @default.
- Q37292354 description "wissenschaftlicher Artikel" @default.
- Q37292354 description "наукова стаття, опублікована у вересні 2016" @default.
- Q37292354 description "научни чланак" @default.
- Q37292354 description "مقالة علمية نشرت في 28 سبتمبر 2016" @default.
- Q37292354 name "Application of interferon modulators to overcome partial resistance of human ovarian cancers to VSV-GP oncolytic viral therapy" @default.
- Q37292354 name "Application of interferon modulators to overcome partial resistance of human ovarian cancers to VSV-GP oncolytic viral therapy" @default.
- Q37292354 name "Application of interferon modulators to overcome partial resistance of human ovarian cancers to VSV-GP oncolytic viral therapy" @default.
- Q37292354 type Item @default.
- Q37292354 label "Application of interferon modulators to overcome partial resistance of human ovarian cancers to VSV-GP oncolytic viral therapy" @default.
- Q37292354 label "Application of interferon modulators to overcome partial resistance of human ovarian cancers to VSV-GP oncolytic viral therapy" @default.
- Q37292354 label "Application of interferon modulators to overcome partial resistance of human ovarian cancers to VSV-GP oncolytic viral therapy" @default.
- Q37292354 prefLabel "Application of interferon modulators to overcome partial resistance of human ovarian cancers to VSV-GP oncolytic viral therapy" @default.
- Q37292354 prefLabel "Application of interferon modulators to overcome partial resistance of human ovarian cancers to VSV-GP oncolytic viral therapy" @default.
- Q37292354 prefLabel "Application of interferon modulators to overcome partial resistance of human ovarian cancers to VSV-GP oncolytic viral therapy" @default.
- Q37292354 P1433 Q37292354-C1567629-0CEA-4D7C-9B3E-9F536E6C09F2 @default.
- Q37292354 P1476 Q37292354-038622D6-6ED2-486B-BA50-5C94F65E97DA @default.
- Q37292354 P2093 Q37292354-1B09AE42-E19F-4B24-BA22-2C455367675A @default.
- Q37292354 P2093 Q37292354-598255D8-30BF-48E4-A1AB-2379474D38EE @default.
- Q37292354 P2093 Q37292354-7CB49924-AB3A-4068-90FD-0C698DBC708B @default.
- Q37292354 P2093 Q37292354-C2AE6DD0-F114-437B-95C4-391AB7066A13 @default.
- Q37292354 P2093 Q37292354-DEA0BE5B-87AC-4C02-9599-48E071F1A63C @default.
- Q37292354 P2093 Q37292354-F924F0DC-D71F-4ECF-AF5D-5DF1C85C9170 @default.
- Q37292354 P2093 Q37292354-FF8F288C-C881-4FF4-AAF1-24D911247D81 @default.
- Q37292354 P2860 Q37292354-03EBC3DA-3505-439E-B0C7-EBAA6DD8B1F0 @default.
- Q37292354 P2860 Q37292354-042097AB-3713-465D-A27A-4134FC8B1A09 @default.
- Q37292354 P2860 Q37292354-06AB6D5B-6733-41E7-8E76-B695983E7596 @default.
- Q37292354 P2860 Q37292354-1723ADCC-A9F6-4AC7-9329-EA6EF540BEF3 @default.
- Q37292354 P2860 Q37292354-1CA7AFF6-5F57-42D1-BE6B-03781B20FE72 @default.
- Q37292354 P2860 Q37292354-26B85843-0FCD-4258-924D-CF11BC10D914 @default.
- Q37292354 P2860 Q37292354-32AD4C72-D7E7-4752-B2B8-DAFBE7D45B63 @default.
- Q37292354 P2860 Q37292354-339BFE17-3504-42D8-A383-11DD53D095DA @default.
- Q37292354 P2860 Q37292354-3921E8B0-CC72-481D-977B-1C90A0C0104E @default.
- Q37292354 P2860 Q37292354-3B412B4B-79C9-4C8F-B4EB-EAAED285C6A7 @default.
- Q37292354 P2860 Q37292354-4157477B-EA1E-48B6-AF09-F755959BD5A2 @default.
- Q37292354 P2860 Q37292354-4663D791-C19B-4AD2-8B36-5C623B25BC6D @default.
- Q37292354 P2860 Q37292354-4914FE2B-F02F-4466-888B-476D0A286199 @default.
- Q37292354 P2860 Q37292354-4A63C096-678B-4906-A966-2DDAA0F93137 @default.
- Q37292354 P2860 Q37292354-504B6D23-72C3-458C-B9AF-41D3F80D3AAC @default.
- Q37292354 P2860 Q37292354-53B7967B-AA91-4505-8B8D-B3C8C9160BFB @default.
- Q37292354 P2860 Q37292354-58827419-A91F-42D1-81CB-13D1A74F5E76 @default.
- Q37292354 P2860 Q37292354-5ED54531-94C6-40CB-9DED-92DF17419931 @default.
- Q37292354 P2860 Q37292354-68A93ACC-8EC2-47BA-969F-07553C33CE47 @default.
- Q37292354 P2860 Q37292354-6EBC899C-F3EF-4EC4-8769-5ADDA9DAE844 @default.
- Q37292354 P2860 Q37292354-707A97B5-FFDD-444C-A7C1-D0CBCAA5B3B2 @default.
- Q37292354 P2860 Q37292354-71F2E932-54F6-4246-9C7A-7EF9D7ADB26B @default.
- Q37292354 P2860 Q37292354-73070707-EE8F-42EE-8B5A-7326B6F00DA3 @default.
- Q37292354 P2860 Q37292354-769E01EE-93CA-450F-ABE8-96F216C238A6 @default.
- Q37292354 P2860 Q37292354-7E0B5A2D-DC8D-48B1-9195-626BAEABE0C4 @default.
- Q37292354 P2860 Q37292354-8EB104DD-2DF5-4A2C-A185-B9C08C6A1886 @default.
- Q37292354 P2860 Q37292354-99A1005D-AF73-4151-B074-A8BF8C1B6A6A @default.
- Q37292354 P2860 Q37292354-A1999EBA-EE8E-42AB-B0CE-A108EF9CEE8E @default.
- Q37292354 P2860 Q37292354-A2F7D9D0-44F8-4971-BE08-E788E9FDD0B1 @default.
- Q37292354 P2860 Q37292354-A64CD85B-B4F6-40D6-BCB1-AA1623FA873C @default.
- Q37292354 P2860 Q37292354-AE10EA9D-F67F-4745-ACED-56774233A0B1 @default.
- Q37292354 P2860 Q37292354-B24D439D-74DA-4BBC-8D43-C04CAD15EEF9 @default.
- Q37292354 P2860 Q37292354-B45ADA61-B4E0-4AAF-81AB-F7DBD136F60E @default.
- Q37292354 P2860 Q37292354-B924F700-D49E-40F7-BEC8-0E79DB2BC610 @default.
- Q37292354 P2860 Q37292354-C18F5279-4694-406E-96B4-D3702C99D606 @default.
- Q37292354 P2860 Q37292354-C4E4FAF5-3622-43F9-9D02-E7C9E94FA4C2 @default.
- Q37292354 P2860 Q37292354-C7577D6C-D5CA-4F82-BD91-56E50D3659EA @default.
- Q37292354 P2860 Q37292354-D85A0B64-2A67-46D5-8016-FF360B9C18C8 @default.
- Q37292354 P2860 Q37292354-DDB7348B-87CF-4452-8120-EF928E3A945A @default.
- Q37292354 P2860 Q37292354-E05A57A1-C7BB-4C4F-BDBD-3B086BE4BB22 @default.
- Q37292354 P2860 Q37292354-EACC5A01-793E-4B3D-8944-A17B4E888205 @default.
- Q37292354 P2860 Q37292354-EDAFB2B1-BBDD-4233-ADE6-AB8CA486E1F0 @default.
- Q37292354 P2860 Q37292354-F2B11ED0-8E4E-4D3D-BE72-21CB6B6DA9DB @default.
- Q37292354 P2860 Q37292354-F32C39A8-4050-471F-9910-86C045CCB695 @default.
- Q37292354 P2860 Q37292354-FF44AC44-863C-4107-947A-DE9DD7223BEF @default.
- Q37292354 P2860 Q37292354-FFC76417-303D-405E-9CEB-62E35DF5A07B @default.
- Q37292354 P304 Q37292354-BC7DA1A7-B814-4799-9CB5-3F369EEC8983 @default.
- Q37292354 P31 Q37292354-5778BA05-4F45-47FE-8AB3-3BC877578755 @default.
- Q37292354 P356 Q37292354-28C49E65-4476-4277-8ED5-C74AF1D161F5 @default.
- Q37292354 P478 Q37292354-CB058266-7B6E-4E62-87A7-6BEC15FA38BB @default.
- Q37292354 P50 Q37292354-06BF626B-967F-4F8D-B1C2-BBBB1FA60929 @default.
- Q37292354 P50 Q37292354-22F7DEE9-BB59-438B-ACAB-117B27F5EFEF @default.
- Q37292354 P50 Q37292354-51B07CCE-C6ED-4839-ADC7-80369D5ACE11 @default.
- Q37292354 P577 Q37292354-7405961B-E852-4F8F-886F-EEB2B24D2350 @default.
- Q37292354 P698 Q37292354-72ACDF3F-B3A0-4EC9-8B65-7A18657D4177 @default.
- Q37292354 P921 Q37292354-632BD7E6-C70F-4C5E-8681-5146C300286D @default.
- Q37292354 P921 Q37292354-80A4B94F-919C-4E0F-8593-A2CB0ED7C2E2 @default.
- Q37292354 P932 Q37292354-3E17B135-3358-469F-BCBB-5B9C100DB42A @default.
- Q37292354 P356 MTO.2016.21 @default.
- Q37292354 P698 27738655 @default.
- Q37292354 P1433 Q27726823 @default.
- Q37292354 P1476 "Application of interferon modulators to overcome partial resistance of human ovarian cancers to VSV-GP oncolytic viral therapy" @default.
- Q37292354 P2093 "Carles Rodriguez Urbiola" @default.
- Q37292354 P2093 "Catherine Dold" @default.
- Q37292354 P2093 "Christian Marth" @default.